FDA Approves OXYCODONE AND ASPIRIN — Epic Pharma, LLC
Epic Pharma, LLC received FDA approval for its ANDA040910 on July 16, 2020, to manufacture and market generic oxycodone and aspirin in oral tablets. This approval expands the manufacturer’s portfolio, further intensifying North American generic competition for this combination analgesic.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed